中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 12
Dec.  2021
Turn off MathJax
Article Contents

Association of primary intrahepatic lithiasis with the polymorphisms of the cystic fibrosis transmembrane conductance regulator gene

DOI: 10.3969/j.issn.1001-5256.2021.12.028
Research funding:

Social Development Science and Technology Project of Fujian Province (2016Y0068);

Fujian Medical University Sailing Fund Program (2017XQ1205)

  • Received Date: 2021-05-03
  • Accepted Date: 2021-05-24
  • Published Date: 2021-12-20
  •   Objective  To investigate the association of common polymorphism loci of the cystic fibrosis transmembrane conductance regulator (CFTR) gene with the onset of primary intrahepatic lithiasis (PIL) in the Chinese Han population.  Methods  A total of 104 patients with PIL who attended The 900th Hospital of PLA Joint Logistics Support Force from June to November 2018 were enrolled as PIL group, and 120 healthy controls who underwent physical examination during the same period of time were enrolled as control group. Sanger sequencing was used to detect the alleles and genotypes at the M470V, TG-repeats, and Poly-T loci of the CFTR gene. The two groups were compared in terms of age, sex ratio, age of onset, and allele and genotype frequencies, and the association of the above three polymorphism loci of the CFTR gene with the risk of PIL was analyzed. The K-S test was used to determine the normality of continuous variables. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the chi-square test was used to compare categorical data and allele/genotype frequencies and analyze Hardy-Weinberg equilibrium. A binary logistic regression analysis was used to investigate the association of genotypes and alleles with the risk of the disease. The association of the loci deviating from Hardy-Weinberg equilibrium with the risk of PIL was expressed as adjusted odds ratio (OR).  Results  There were significant differences between the PIL group and the control group in the distribution of alleles (χ2=15.139, P < 0.01) and genotypes (χ2=22.889, P < 0.01) at the M470V locus, while there were no significant differences between the two groups in the distribution of alleles and genotypes at the TG-repeats and Poly-T loci (all P > 0.05). The PIL group had a significantly higher frequency of G allele at the M470V locus than the control group (60.1% vs 41.67%, P < 0.01). Compared with the individuals with AA genotype, the individuals with GG and AG genotypes had a significant increase in the risk of PIL (OR=4.680 and 2.500, both P < 0.01). As for the TG-repeats locus, the individuals with 12TG/13TG genotype had a significantly higher risk of PIL than those with 11TG/12TG genotype (OR=11.002, P=0.042), and as for the Poly-T locus, the individuals with 7T/5T genotype had a significantly lower risk of PIL than those with 7T/7T genotype (OR=0.079, P=0.047).  Conclusion  The M470V polymorphism of the CFTR gene is independently associated with the risk of PIL in the Chinese Han population, and G allele is a high-risk mutation for the onset of PIL.

     

  • loading
  • [1]
    TORRES O, LINHARES MM, RAMOS E, et al. Liver Resection for Non-oriental Hepatolithiasis[J]. Arq Bras Cir Dig, 2019, 32(4): e1463. DOI: 10.1590/0102-672020190001e1463.
    [2]
    CHA SW. Management of intrahepatic duct stone[J]. Korean J Gastroenterol, 2018, 71(5): 247-252. DOI: 10.4166/kjg.2018.71.5.247.
    [3]
    SHANG D, ZHANG GX, ZHANG QK. Minimally invasive integrated traditional Chinese and Western medicine therapy for hepatolithiasis based on the SELECT concept[J]. J Clin Hepatol, 2020, 36(1): 31-35. DOI: 10.3969/j.issn.1001-5256.2020.01.005.

    尚东, 张桂信, 张庆凯. 基于SELECT理念的中西医结合微创治疗肝胆管结石[J]. 临床肝胆病杂志, 2020, 36(1): 31-35. DOI: 10.3969/j.issn.1001-5256.2020.01.005.
    [4]
    LI C, WEN T. Surgical management of hepatolithiasis: A minireview[J]. Intractable Rare Dis Res, 2017, 6(2): 102-105. DOI: 10.5582/irdr.2017.01027.
    [5]
    CHEN W, YANG WQ, MENG XL, et al. Research progress in etiology of primary hepatolithiasis[J]. J Clin Hepatol, 2005, 21(3): 180-181. DOI: 10.3969/j.issn.1001-5256.2005.03.026.

    陈伟, 杨文奇, 孟翔凌, 等. 原发性肝内胆管结石的病因学研究现状[J]. 临床肝胆病杂志, 2005, 21(3): 180-181. DOI: 10.3969/j.issn.1001-5256.2005.03.026.
    [6]
    WEBER SN, BOPP C, KRAWCZYK M, et al. Genetics of gallstone disease revisited: Updated inventory of human lithogenic genes[J]. Curr Opin Gastroenterol, 2019, 35(2): 82-87. DOI: 10.1097/MOG.0000000000000511.
    [7]
    RAN X, YIN B, MA B. Four major factors contributing to intrahepatic stones[J]. Gastroenterol Res Pract, 2017, 2017: 7213043. DOI: 10.1155/2017/7213043.
    [8]
    AL SINANI S, AL-MULAABED S, AL NAAMANI K, et al. Cystic fibrosis liver disease: Know more[J]. Oman Med J, 2019, 34(6): 482-489. DOI: 10.5001/omj.2019.90.
    [9]
    HUANG Q, DING W, WEI MX. Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population[J]. World J Gastroenterol, 2008, 14(12): 1925-1930. DOI: 10.3748/wjg.14.1925.
    [10]
    PAGIN A, SERMET-GAUDELUS I, BURGEL PR. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders[J]. Arch Pediatr, 2020, 27(Suppl 1): eS25-eS29. DOI: 10.1016/S0929-693X(20)30047-6.
    [11]
    European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones[J]. J Hepatol, 2016, 65(1): 146-181. DOI: 10.1016/j.jhep.2016.03.005.
    [12]
    Group of Biliary Tract Surgery, Chinese Society of Surgery, Chinese Medical Association. The trend of the gallstone disease in China over the past decade[J]. Chin J Surg, 1995, 33(11): 652-658. DOI: 10.3760/j:issn:0529-5815.1995.11.007.

    中华外科学会胆道外科学组. 我国胆石病十年来的变迁[J]. 中华外科杂志, 1995, 33(11): 652-658. DOI: 10.3760/j:issn:0529-5815.1995.11.007.
    [13]
    ZSEMBERY A, JESSNER W, SITTER G, et al. Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells[J]. Hepatology, 2002, 35(1): 95-104. DOI: 10.1053/jhep.2002.30423.
    [14]
    SAKIANI S, KLEINER DE, HELLER T, et al. Hepatic manifestations of cystic fibrosis[J]. Clin Liver Dis, 2019, 23(2): 263-277. DOI: 10.1016/j.cld.2018.12.008.
    [15]
    EMINOGLU TF, POLAT E, GÖKÇE S, et al. Cystic fibrosis presenting with neonatal cholestasis simulating biliary atresia in a patient with a novel mutation[J]. Indian J Pediatr, 2013, 80(6): 502-504. DOI: 10.1007/s12098-012-0842-5.
    [16]
    KO JM, KIM GH, KIM KM, et al. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis[J]. J Korean Med Sci, 2008, 23(5): 912-915. DOI: 10.3346/jkms.2008.23.5.912.
    [17]
    KHAN HH, MEW NA, KAUFMAN SS, et al. Unusual cystic Fibrosis transmembrane conductance regulator mutations and liver disease: A case series and review of the literature[J]. Transplant Proc, 2019, 51(3): 790-793. DOI: 10.1016/j.transproceed.2018.11.007.
    [18]
    WAHABI I, HADJ FREDJ S, NEFZI M, et al. Association of M470V polymorphism of CFTR gene with variability of clinical expression of asthma: Case-report study[J]. Allergol Immunopathol (Madr), 2019, 47(2): 159-165. DOI: 10.1016/j.aller.2018.06.007.
    [19]
    JIN CX, FUJIKI K, SONG Y, et al. CFTR polymorphisms of healthy individuals in two Chinese cities-Changchun and Nanjing[J]. Nagoya J Med Sci, 2012, 74(3-4): 293-301. DOI: 10.1111/j.1582-4934.2011.01493.x.
    [20]
    JIANG L, JIN J, WANG S, et al. CFTR gene mutations and polymorphism are associated with non-obstructive azoospermia: From case-control study[J]. Gene, 2017, 626: 282-289. DOI: 10.1016/j.gene.2017.04.044.
    [21]
    SALINAS DB, AZEN C, YOUNG S, et al. Phenotypes of california CF newborn screen-positive children with CFTR 5T allele by TG repeat length[J]. Genet Test Mol Biomarkers, 2016, 20(9): 496-503. DOI: 10.1089/gtmb.2016.0102.
    [22]
    JIANG M, LI Z, FU S, et al. IVS8-5T Allele of CFTR is the risk factor in chronic pancreatitis, especially in idiopathic chronic pancreatitis[J]. Am J Med Sci, 2020, 360(1): 55-63. DOI: 10.1016/j.amjms.2020.04.019.
    [23]
    QIAO D, YI L, HUA L, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: A case-control study in Chinese Han population[J]. J Cyst Fibros, 2008, 7(3): 210-214. DOI: 10.1016/j.jcf.2007.07.011.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(6)

    Article Metrics

    Article views (247) PDF downloads(25) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return